The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion
Abstract
Ectopic ACTH syndrome (EAS) is rare but is frequently a severe condition because of the intensity of the hypercortisolism that may be dissociated from the tumoral condition. EAS should often be considered as an endocrine emergency requiring an emergency response both in terms of diagnostic procedures and therapeutic interventions. Patient management is complex and necessitates dual skills, in the diagnosis and treatment of CS and in the specific management of neuroendocrine tumors (NET). Therefore, initial management should be performed ideally by experienced endocrinology teams in collaboration with specialized hormonal laboratory, modern imaging platforms and intensive care units. Diagnostic procedures vary according to the endocrine and tumoral contexts but should be reduced to a minimum in intense hypercortisolism. Preventive and curative treatments of cortisol-induced comorbidities, non-specific management of hypercortisolism and etiological treatments should be considered simultaneously. Therapeutic strategies vary according to (1.) the intensity of hypercortisolism, the general condition of the patient and associated comorbidities and (2.) the tumoral status, ranging from resectable ACTH secreting tumors to non-resectable metastatic endocrine tumors or occult tumors. The ideal treatment is complete excision of the ACTH-secreting tumor that can be performed rapidly or after preoperative preparation using cortisol-lowering drugs. When this is not possible, the therapeutic strategy should be discussed by a multidisciplinary experienced team in a personalized perspective and include variable combinations of pharmacological agents, bilateral adrenalectomy and non-specific tumoral interventions. Here we discuss the diagnosis and therapeutic strategies including the modern, currently available tools and emphasize on the operational effectiveness of care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second-line tests include functional imaging using 68Ga-PET/CT or 18FDG PET/CT scans, which can be used to detect occult tumors, reinforce tumors seen on CT scan as being neuroendocrine, or contribute to the workup of metastatic tumors (9, 81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Desmopressin testing can also be used because type 2 vasopressin receptors, which are generally absent in normal pituitary corticotrophs, have found to be expressed in corticotroph adenomas.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Therefore, an increase in plasma ACTH and cortisol can be observed after injection of desmopressin in patients with Cushing disease (81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Dynamic testing with high-dose DST, CRH test, and desmopressin testing can also be used to help differentiate between Cushing disease and EAS (9, 81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“On the other hand, an absence of both ACTH and cortisol is expected in patients with EAS, although false-positive results can be seen as EAS tumors may express type 3 vasopressin receptors (9, 74, 81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Patients with EAS are typically unresponsive although some tumors, in particular bronchial carcinoids can express CRH receptors (9, 74, 81, 82).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“The CRH test is useful because corticotroph pituitary adenomas express CRH receptors and associated downstream cell-signaling pathway molecules, thereby responding to CRH by releasing excess ACTH compared with ectopic ACTH-secreting tumors (81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Therefore, most but not all patients with Cushing disease will have an increase in plasma ACTH by more than 50% and cortisol concentrations by more than 20% after CRH stimulation.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
Citations
Cites
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Self-citationRindi, G., Klimstra, D. S., Abedi‐Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E. M., BUSAM, K. J., de Krijger, R. R., Dietel, M., El‐Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,164
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Pavel, M., Baudin, É., Couvelard, A., Krenning, E. P., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B. J., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 868
Oldfield, E. H., Doppman, J. L., Nieman, L. K., Chrousos, G. P., Miller, D. L., Katz, D. A., Cutler, G. B., & Loriaux, D. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251301 · Cited by 855
Caplin, M. E., Baudin, É., Ferollà, P., Filosso, P. L., García‐Yuste, M., Lim, E. K. S., Öberg, K., Pelosi, G., Perren, A. A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 713
Olsson, C. A., & Vickery, A. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197603252941310 · Cited by 711
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 667
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 615
Isidori, A. M., Kaltsas, G., Pozza, C., Frajese, V., Newell-Price, J. D. C., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 525
Cited by
Sorted by citations
Items 201–239 of 239
Common electrolyte imbalance, uncommon cause
Agrawal, S. S., Kumar, S., Soni, N., & Paliwal, S. (2025) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.92a.24013
Hickey, K. E., Yaremko, H., Orr, C., & Pace, D. (2025) · Current Oncology · doi:10.3390/curroncol32040205
Cushing's syndrome screening and differential diagnosis
Lacroix, A., & Nieman, L. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00233-8
Cushing’s Syndrome due to a Renal Neuroendocrine Tumor: A Case Report
Poudyal, V., Elston, M. S., Nottingham, S., Swarbrick, M. J., Davies, A., & Boyle, V. (2025) · Case Reports in Oncology · doi:10.1159/000545734
Sun, F., Sun, Y., He, H., Zhao, Z., Zhang, H., Jiang, N., & Zhu, Z. (2025) · Clinical Case Reports · doi:10.1002/ccr3.70660
Ferrière, A., & Tabarin, A. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.07.002
Self-citationSonuşen, Ş. D., Bilen, İ., Kuzu, Ö. F., Demir, Ö., Bükün, H. O., Muğlu, H., Koçanoğlu, A., Eşdur, P. Ç., Bayramgil, A., Can, O., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3716
Endocrine manifestations of adult malignancy
Michaelidou, M., Sankar, A., & Dhage, S. S. (2025) · Medicine · doi:10.1016/j.mpmed.2025.07.013
Tsoli, M., Bel-Ange, A., Atlan, K., Ben‐Haim, S., Kaltsas, G., & Grozinsky‐Glasberg, S. (2025) · Current Treatment Options in Oncology · doi:10.1007/s11864-025-01354-0
Kızılgül, M., Diaz‐Gutierrez, I., Mogrovejo, D. O., Ahmed, A., Burmeister, L. A., & Zekarias, K. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.10.016
Deng, H., Lin, S., He, H., Xie, S., Chen, J., Zeng, L., & Xu, W. (2025) · Medicine Plus · doi:10.1016/j.medp.2025.100109
Bel-Ange, A., & Grozinsky‐Glasberg, S. (2025) · Endocrinology · doi:10.1007/978-3-031-83281-9_10
Castro, M. A., García-Centeno, R., Aller, J., Marazuela, M., Soto, A., Gálvez, M. A., Cámara, R., Valassi, E., Bernabéu, I., Villar‐Taibo, R., et al. (2025) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.501654
Ancha, B., Ermolovich, J., & Harry-Hernández, S. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-268512
Cao, X.-Y., Deng, H.-B., & Jiang, P.-B. (2026) · AME Case Reports · doi:10.21037/acr-24-271
Ling, F., Wu, M., GuoYu, Zhou, R., Han, L., Wang, J., Ma, L., & Jia, A. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02171-8
Ectopic ACTH production from oesophageal neuroendocrine carcinoma causing Cushing syndrome
Zhang, Y., Zhang, X., & Majumdar, S. K. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-265632
Ectopic ACTH- or CRH-producing tumors and Cushing’s syndrome
Kefeli, M., & Mete, Ö. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00002-8
Cushing’s disease: Pituitary tumors causing CS—Diagnosis and treatment
Alcubierre, D. D., Kassi, E., Isidori, A. M., & Hasenmajer, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00010-7
Surgical issues for a patient with Cushing's syndrome: Techniques, complications, and recovery
Dinerman, A. J., & Nilubol, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00009-0
Gallbladder neuroendocrine carcinoma: a rare cause of ectopic ACTH secretion
Tandon, A., Mohanta, B. B., , R., & Dabadghao, P. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-269836
Hepatic embolization for Cushing syndrome from metastatic tumors: a single-center case series
Zhang, S., Mosquera, J. E., Musonza, C., Pillai, A., Abramowitz, J. D., Mirfakhraee, S., Polanco, P. M., Mutar, S. S. A., Arafat, W., & Hamidi, O. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag046
Ectopic ACTH-dependent Cushing syndrome due to mature ovarian teratoma
Eisa, N. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-271716
Ectopic Cushing’s syndrome: Clinical presentation and diagnosis
Morelli, V., & Musolino, A. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2026.02.003
Majumder, M., Clarke, S. J., Bernard, E., & Tsang, V. (2026) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-25-0138
Biochemical diagnosis of hypercortisolism: When and how?
Asla, Q., Urgell, E., Terzan, S., Marín, R., Vives, A. S., Webb, S. M., & Aulinas, A. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2026.03.001
Cyclic Cushing syndrome as a clinical enigma and diagnostic dilemma in advanced endocrinology
Ilkiv, Y., Potapova, K., Yerokhovych, V., & Kobyliak, N. M. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02910-7
Research Progress in Diagnostic Methods of Cushing’s Syndrome
郭, 林. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662449
Case 24: A 42-Year-Old Woman With Fever and Shock
Bae, S., Lee, J., Ha, J., Lim, D., & Lee, J. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e195
Bitaraf, M., & Memarian, M. (2026) · Journal of Preventive Epidemiology · doi:10.34172/jpe.39326
Metyrapone in the Management of Severe Hypercortisolism Secondary to Ectopic Cushing’s Syndrome
Sydney, G. I., Ntelis, S., & Majumdar, S. K. (2026) · Case Reports in Endocrinology · doi:10.1155/crie/1796526
Pokrzywa, A., Domański, J., Roszkowska, Z., Koperski, Ł., Wąsowski, D., Ambroziak, U., Pachucki, J., & Bobrowicz, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1898005
Oksenberg, S., Nilo, F., Pablo Villanueva, G., Hernández, M. I., González, C., Cruz, J. P., Baudrand, R. F., Uslar, T., Domínguez, J. M., & Guarda, F. J. (2026) · Revista médica de Chile · doi:10.4067/s0034-98872026000701113
郭, 林., Liu, Y., Li, S., Yu, X., Wang, K., & Yan, F. (2026) · PeerJ · doi:10.7717/peerj.21677
Arrivi, G., Pagnanelli, M., Puliani, G., Zerbi, A., Partelli, S., & Panzuto, F. (2026) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2026.100428
An Overview of Cushing’s Syndrome Caused by Ectopic Adrenocorticotropin Secretion
Ilias, Ι., Maggio, V., Ispas, S., Hoffmann, K., Paczkowska, A., Арманович, А. А., Rangraze, I. R., Wali, A. F., Talath, S., Rabbani, S. A., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15208192
Katari, G. (2026) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v14i10.08
Ectopic cushing syndrome caused by intestinal neuroendocrine tumors: a systematic review
Guerrero‐Pérez, F., Sánchez-Barrera, R., de la Bellacasa, J. P., Serrano, T., Vercher-Conejero, J. L., Peiró, I., & Iglesias, P. (2026) · Endocrine · doi:10.1007/s12020-026-04831-0
Chacko, S. R., Peersen, A. F., Kaplan, J. M., Belaya, Z. E., Lu, L., Yu, K., Torres, C. A. V., Atkinson, E. J., Young, W. F., Waguespack, S. G., et al. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00237-8
Self-citation
Metadata
- Authors
- Young, J., Haissaguerre, M., Viera-Pinto, O., Chabre, O., Baudin, E., & Tabarin, A.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- 1Department of Endocrinology, Paris-Sud University and Paris Saclay University, Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
- Université Joseph Fourier (FR)
- 4Endocrine Oncology and Nuclear Medicine Department, Gustave Roussy Cancer Institute, Paris-Sud University and Paris-Saclay University, Villejuif, France
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04
- Volume
- 182
- Issue
- 4
- Pages
- R29-R58
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W3003251208
- Cited by
- 232
- References
- 189
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 37 · 2023: 45 · 2022: 43 · 2021: 29 · 2020: 8
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- ectopic ACTH syndrome, Cushing's syndrome, hypercortisolism, neuroendocrine tumors, ACTH-secreting tumor, bilateral adrenalectomy, tumor resection, multidisciplinary management, endocrine emergencies
- MeSH terms
- ACTH Syndrome, Ectopic, Cushing Syndrome, Endocrinology, Humans, Treatment Outcome, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
